These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14762380)

  • 1. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.
    Sparicio D; Landoni G; Pappalardo F; Crivellari M; Cerchierini E; Marino G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):592-3. PubMed ID: 14762380
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.
    Del Duca D; Sheth SS; Clarke AE; Lachapelle KJ; Ergina PL
    Ann Thorac Surg; 2009 Feb; 87(2):640-2. PubMed ID: 19161806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
    Yiu P; Robin J; Pattison CW
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.
    Grayling M; Deakin CD
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):426-7. PubMed ID: 12579121
    [No Abstract]   [Full Text] [Related]  

  • 6. The response to methylene blue in patients with severe hypotension during liver transplantation.
    Cheng SS; Berman GW; Merritt GR; Hendrickse A; Fiegel MJ; Teitelbaum I; Campsen J; Wachs M; Zimmerman M; Mandell MS
    J Clin Anesth; 2012 Jun; 24(4):324-8. PubMed ID: 22608589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylene blue: usefulness in the treatment of refractory hypotension in premature infants].
    López-Suárez O; Pérez-Muñuzuri A; Baña-Souto A; Crespo-Suárez P; Couce-Pico ML; Fernández-Lorenzo JR
    An Pediatr (Barc); 2011 Mar; 74(3):209-10. PubMed ID: 21300579
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
    Lutjen DL; Arndt KL
    AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
    Taylor K; Holtby H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):566. PubMed ID: 16077431
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.
    Sparicio D; Landoni G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):608. PubMed ID: 14762391
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
    Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
    Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methylene blue against refractory hypotension].
    Morgan D; Rasmussen MG; Barklin A
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
    Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium-induced nephrogenic diabetes insipidus after coronary artery bypass.
    Leeman MF; Vuylsteke A; Ritchie AJ
    Ann Thorac Surg; 2007 Aug; 84(2):656-7. PubMed ID: 17643658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue for the treatment of refractory anaphylaxis without hypotension.
    Bauer CS; Vadas P; Kelly KJ
    Am J Emerg Med; 2013 Jan; 31(1):264.e3-5. PubMed ID: 22633725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
    Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
    Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: Does it matter?
    Konety SH; Rosenthal GE; Vaughan-Sarrazin MS
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1116-23.e1. PubMed ID: 19379976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.